12 IPOs raised $3.7 billion this past week, led by software maker UiPath (PATH), which raised more than $1 billion in its public debut. The pipeline remained active, with 11 IPOs and one direct listing submitting initial filings. SPAC activity...read more
NeuroPace, which makes a brain-responsive neuromodulation system for drug-resistant epilepsy, is expected to begin trading on the Nasdaq on Thursday. The company raised $102 million in its IPO by offering 6.0 million shares at $17, the high end of the range of...read more
NeuroPace, which makes a brain-responsive neuromodulation system for drug-resistant epilepsy, raised $102 million by offering 6 million shares at $17, the high end of the price range of $15 to $17. The company offered 0.7 million more shares than...read more
Updated Monday, 4/19. 11 IPOs are scheduled to raise a total of $3.6 billion in the week ahead, led by software maker UiPath (PATH). The largest IPO of the week, UiPath (PATH) plans to raise $990 million...read more
US IPO Weekly Recap: UiPath’s billion-dollar deal leads a 12 IPO Week
12 IPOs raised $3.7 billion this past week, led by software maker UiPath (PATH), which raised more than $1 billion in its public debut. The pipeline remained active, with 11 IPOs and one direct listing submitting initial filings. SPAC activity...read more
Epilepsy device maker NeuroPace set to begin trading on Thursday after CFIUS delay; priced an upsized IPO at $17 high end
NeuroPace, which makes a brain-responsive neuromodulation system for drug-resistant epilepsy, is expected to begin trading on the Nasdaq on Thursday. The company raised $102 million in its IPO by offering 6.0 million shares at $17, the high end of the range of...read more
Epilepsy medical device developer NeuroPace prices upsized IPO at $17 high end
NeuroPace, which makes a brain-responsive neuromodulation system for drug-resistant epilepsy, raised $102 million by offering 6 million shares at $17, the high end of the price range of $15 to $17. The company offered 0.7 million more shares than...read more
US IPO Week Ahead: Software, synthetic biology, and more in an 11 IPO week
Updated Monday, 4/19. 11 IPOs are scheduled to raise a total of $3.6 billion in the week ahead, led by software maker UiPath (PATH). The largest IPO of the week, UiPath (PATH) plans to raise $990 million...read more